Rockefeller Capital Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,000
| Closed | -$2K | – | 4153 |
|
|
2022
Q4 | $2K | Buy |
7,000
+5,000
| +250% | +$1.43K | ﹤0.01% | 3624 |
|
|
2022
Q3 | $0 | Hold |
2,000
| – | – | ﹤0.01% | 4535 |
|
|
2022
Q2 | $0 | Hold |
2,000
| – | – | ﹤0.01% | 4495 |
|
|
2022
Q1 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 3670 |
|
|
2021
Q4 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 3594 |
|
|
2021
Q3 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 3283 |
|
|
2021
Q2 | $3K | Hold |
2,000
| – | – | ﹤0.01% | 3209 |
|
|
2021
Q1 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 2989 |
|
|
2020
Q4 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 2526 |
|
|
2020
Q3 | $4K | Buy |
+2,000
| New | +$4K | ﹤0.01% | 2309 |
|